"Development of Interstitial Lung Disease Among Patients With Atrial Fibrillation Receiving Oral Anticoagulants in Taiwan"

LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

This cohort study evaluates the risk of new-onset idiopathic interstitial lung disease among patients receiving factor Xa inhibitors, dabigatran, or warfarin. Click to show full abstract

This cohort study evaluates the risk of new-onset idiopathic interstitial lung disease among patients receiving factor Xa inhibitors, dabigatran, or warfarin.

Keywords: disease among; lung disease; among patients; interstitial lung

Journal Title: JAMA Network Open
Year Published: 2022

Link to full text (if available)

Share on Social Media: Sign Up to like & get
recommendations!
1

LAUSR

You are not signed in:

Sign Up!

Related content

More Information News Social Media Video Recommended